MedPath
HSA Approval

RETORIN POWDER FOR SUSPENSION 200 mg/5 ml

SIN11245P

RETORIN POWDER FOR SUSPENSION 200 mg/5 ml

RETORIN POWDER FOR SUSPENSION 200 mg/5 ml

December 16, 1999

UNI DRUG HOUSE

UNI DRUG HOUSE

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantUNI DRUG HOUSE
Licence HolderUNI DRUG HOUSE

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

POWDER, FOR SUSPENSION

ORAL

Medical Information

J01FA01

erythromycin

Manufacturer Information

UNI DRUG HOUSE SDN. BHD.

SM PHARMACEUTICALS SDN BHD

Active Ingredients

ERYTHROMYCIN ETHYLSUCCINATE EQV ERYTHROMYCIN

200 mg/5 ml

Erythromycin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.